Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
73 /100
HIGH RISK
Score updated Oct 13, 2026

TPST — Tempest Therapeutics, Inc. Dilution Risk Tracker

Track TPST dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TPST — Get alerts when the score changes →

As of October 13, 2026, Tempest Therapeutics, Inc. (TPST) has a DilutionWatch DilutionScore of 73/100, rated HIGH dilution risk. Tempest Therapeutics, Inc. has a market capitalization of $11.00M, 14.81M shares outstanding, 1 institutional holders tracked. Stored dilution-related fields include 17.1K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
85
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 35%
🔄 Reverse Split model est. 45%
• 50-day avg $1.85 approaching $1 threshold
• Only 6 months cash — financial pressure
💰 Capital Raise model 35%
• Low cash runway: 6 months remaining
📉 Score Deterioration model 10%
• Score in HIGH risk zone (73/100)
🔔 Track TPST — Get forecast alerts →

Market Data

Market Cap$11.00M
Shares Outstanding14.81M
Float9.27M
Cash$15.21M
Debt$199.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore73/100DilutionWatch score record
Shares Outstanding14.81MVerified float table or market cache
Public Float9.27MVerified float table or market cache
Market Cap$11.00MMarket data cache
Cash Runway5.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants17.1KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

1 institutional holders · 269.8K shares
#1 Versant Venture Management, LLC 269.8K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest608.4K
Days to Cover1.0
% of Float6.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-13
xbrl XBRL CONVERTIBLE 2023-03-22
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TPST Dilution Snapshot

Tempest Therapeutics, Inc. (TPST) has a DilutionScore of 73/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TPST's DilutionScore is currently 73/100 (High risk), with 3 score changes tracked over 89 days. The score deteriorated from 87/100 (Critical risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202673/100HIGH13 days
Aug 22 – Sep 30, 202687/100CRITICAL40 days
Aug 14 – Aug 21, 202671/100HIGH7 days
Jul 16 – Aug 13, 202681/100CRITICAL29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TPST shares outstanding have increased 6.4% from 13.48M (Mar 2026) to 14.34M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 07, 202614.34M9.27M▲ 1.59%
Apr 01, 202614.34M9.13M▲ 223.05%
Mar 30, 202613.48M2.82M▲ 0.02%
Mar 28, 202613.48M2.82M▼ 2.54%
Mar 27, 202613.48M2.90M▲ 1.86%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TPST Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TPST files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TPST — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TPST
TPST FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.